Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Healthcare | Small Cap
Health Score : 6.94Entero Healthcare Solutions shows a mixed financial picture. The company excels in solvency and profitability, demonstrating a strong ability to meet long-term obligations and generate profits. Its liquidity is also well-managed. However, efficiency in using its capital and managing receivable days is an area of concern. While revenue and operating profit are growing impressively, EPS and net income growth face challenges. The company's coverage ratios are weak, indicating potential difficulties in meeting its interest and dividend obligations. Overall, Entero Healthcare showcases robust profitability and solvency but needs to address efficiency and earnings growth for sustained financial health.
Health Score : 6.94Entero Healthcare Solutions shows a mixed financial picture. The company excels in solvency and profitability, demonstrating a strong ability to meet long-term obligations and generate profits. Its liquidity is also well-managed. However, efficiency in using its capital and managing receivable days is an area of concern. While revenue and operating profit are growing impressively, EPS and net income growth face challenges. The company's coverage ratios are weak, indicating potential difficulties in meeting its interest and dividend obligations. Overall, Entero Healthcare showcases robust profitability and solvency but needs to address efficiency and earnings growth for sustained financial health.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
292.07
Industry Median
30.91
Small Cap Median
28.64
P/E RATIO
68.27
P/B RATIO
4.65
Industry Median
3.69
Small Cap Median
3.11
P/S RATIO
1.17
Industry Median
3.74
Small Cap Median
3.02
Others
PEG RATIO
0.00
EV/EBITDA RATIO
28.31
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹1805 as on Sep 1, 2026.
Growth Score : 6.00The company shows strong growth in revenue and operating profit, indicating effective market strategies. However, negative EPS and net income growth rates are concerning, suggesting profitability is not keeping pace with revenue increases. The company's asset growth is robust, reflecting expansion and investment. Emphasizing recent performance, the weighted average calculation reflects the mixed growth dynamics.
Revenue Growth RateExcellentOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthPoorAsset Growth RateExcellentNet Income Growth RatePoor| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 42.24 | 30.85 | 18.85 | 29.93 | 29.34 |
| Operating Profit Growth Rate | 60 | 166.67 | 75 | 53.57 | 54.65 |
| Earnings Per Share (EPS) Growth | 94.99 | 63.81 | 131.97 | 142.38 | 21.34 |
| Asset Growth Rate | 34.57 | 16.27 | 79.28 | 15.27 | 33.19 |
| Net Income Growth Rate | -93.33 | 62.07 | 463.64 | 167.5 | 36.45 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Medi Assist Healthcare Services Ltd | 8.17 | 28.70 | Neutral | 175.00 | 6.96 | 89.00 |
| 2 | Entero Healthcare Solutions Ltd | 6.94 | 68.27 | Neutral | 266.00 | 6.18 | 146.00 |
| 3 | Krsnaa Diagnostics Ltd | 6.17 | 17.91 | Neutral | 212.00 | 31.65 | 101.00 |
| 4 | Suven Life Sciences Ltd | 5.67 | -36.41 | Neutral | -284.00 | -2.08 | -276.00 |
| 5 | KOVAI | N/A | N/A | N/A | N/A | N/A | N/A |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
No Stock News Available at This Moment.
Entero Healthcare Solutions Ltd is a leading Indian distributor of pharmaceutical products. It offers an integrated distribution platform, connecting manufacturers with pharmacies, hospitals, and clinics nationwide. The company focuses on wide reach, efficient logistics, and technology-driven solutions for healthcare product distribution.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Entero Healthcare Solutions Ltd's P/E ratio (TTM) is 292.07, compared to the industry median of 30.91 and large cap median of 28.64.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Entero Healthcare Solutions Ltd's P/B ratio is 4.65, compared to the industry median of 3.69 and large cap median of 3.11.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Entero Healthcare Solutions Ltd's P/S ratio is 1.17, compared to the industry median of 3.74 and large cap median of 3.02.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Entero Healthcare Solutions Ltd's PEG ratio is N/A.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Entero Healthcare Solutions Ltd's EV/EBITDA ratio is 28.31.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Entero Healthcare Solutions Ltd's ROE is 8.64%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Entero Healthcare Solutions Ltd's ROA is 7.39%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Entero Healthcare Solutions Ltd's ROCE is 11%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Entero Healthcare Solutions Ltd's operating margin is 4.04%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Entero Healthcare Solutions Ltd's net margin is 2.22%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Entero Healthcare Solutions Ltd's current ratio is 1.50.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Entero Healthcare Solutions Ltd's debt-to-equity ratio is 0.14.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Entero Healthcare Solutions Ltd's interest coverage ratio is 4.31.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Entero Healthcare Solutions Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Entero Healthcare Solutions Ltd's EPS is 21.34.
(Source line: "Ratios as of 24 Oct 2026, based on last traded price of ₹1805. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 2018
Headquarters: Noida, Uttar Pradesh
Core Offerings: Pharmaceutical product distribution, Supply chain & logistics, Technology-enabled solutions, Market access services
Stock Listing: NSE (ENTERO), BSE (544122)
Promoter: Prabhat Agrawal / Prem Sethi / OrbiMed Asia
2018: Incorporated with a vision to build a robust pharmaceutical distribution network across India. The company steadily expanded its operations, focusing on comprehensive coverage and efficient logistics. It leveraged technology to enhance its supply chain capabilities. 2024: Successfully launched its Initial Public Offering (IPO) and listed on the NSE and BSE, marking a significant milestone in its growth journey.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Integrated Healthcare Product Distribution | 100% | N/A - Segment-wise EBITDA not reported |
Integrated Healthcare Product Distribution: Entero operates a pan-India pharmaceutical distribution network, catering to pharmacies, hospitals, and clinics.
Broad Product Portfolio: Distributes a wide range of pharmaceutical products, including medicines, medical devices, and other healthcare consumables from various manufacturers.
Advanced Logistics: Utilizes a sophisticated logistics and supply chain management system to ensure timely and efficient delivery across diverse geographical locations.
Technology-Driven: Employs technology platforms for inventory management, order processing, and data analytics to optimize operations and service delivery.
Prabhat Agrawal (Co-Founder, MD & CEO): A visionary leader with extensive experience in pharmaceutical distribution, he has spearheaded Entero's growth and strategic initiatives. Prem Sethi (Co-Founder, Whole-time Director): An experienced professional responsible for driving operational efficiency and expanding the company's robust distribution network.
M.S. Pharma Logistics Private Limited
Pankaj Healthcare Distributors Private Limited
No major recent corporate actions on record.
The Entero Healthcare Solutions Ltd share price today is ₹1805 on NSE (ENTERO), as of 24 Oct 2026.
As of 24 Oct 2026, Entero Healthcare Solutions Ltd share price is ₹1805, with previous close ₹1805. Today's range is ₹1805 to ₹1805. The 52-week range is ₹944 to ₹1920.
As of today, Entero Healthcare Solutions Ltd's market cap is ₹7,743.45 crore (Mid Cap).
Entero Healthcare Solutions Ltd's current P/E ratio is 292.07, compared to the PHARMACEUTICALS & BIOTECHNOLOGY sector average of 43.50.
Entero Healthcare Solutions Ltd's current P/B ratio is 4.65.
Entero Healthcare Solutions Ltd's current dividend yield is N/A. Last dividend of ₹0.00 per share was declared on N/A.
Entero Healthcare Solutions Ltd's EPS (TTM) is ₹21.34.
Entero Healthcare Solutions Ltd is a leading Indian distributor of pharmaceutical products. It offers an integrated distribution platform, connecting manufacturers with pharmacies, hospitals, and clinics nationwide. The company focuses on wide reach, efficient logistics, and technology-driven solutions for healthcare product distribution.
Entero Healthcare Solutions Ltd is promoted by Prabhat Agrawal / Prem Sethi / OrbiMed Asia, holding 52.42% as of 24 Oct 2026.
Entero Healthcare Solutions Ltd is listed on NSE (ENTERO) and BSE (544122). Its next quarterly results are expected on July/August 2024 (Q1 FY25).
Inventory Turnover Ratio